Nasdaq · CIK 0002131813
NWCL newcleo plc
Insider trading from SEC Form 4. Last filing 19 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at newcleo plc, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 16 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Stefano Buono Chief Executive Officer | AGrant or award Stock Options (Right to Buy)derivative | +134,596 | $0.00 | $0 | 134,596 | 19 d ago |
| Sep 21, 2026 | d'Ovidio Manfredi Lefebvre director | AGrant or award Class B Sharesderivativeindirect: By Emmeplus Limited | +326,049 | $0.00 | $0 | 326,049 | 19 d ago |
| Sep 21, 2026 | Andrea Ruben Osvaldo Levi director | AGrant or award Class B Sharesderivativeindirect: By Parabensa S.r.l. | +374,946 | $0.00 | $0 | 374,946 | 19 d ago |
| Sep 21, 2026 | Raffaele Petrone director | AGrant or award Class B Sharesderivativeindirect: By FIN POSILLIPO S.p.A. | +2,030,119 | $0.00 | $0 | 2,030,119 | 19 d ago |
| Sep 21, 2026 | Elisabeth Rizzotti Deputy Ch Ex Off & Ch Oper Off | AGrant or award Stock Options (Right to Buy)derivative | +96,140 | $0.00 | $0 | 96,140 | 19 d ago |
| Sep 21, 2026 | Jon Stranske Group Chief Financial Officer | AGrant or award Ordinary Shares | +6,729 | $0.00 | $0 | 74,027 | 19 d ago |
| Sep 21, 2026 | de Saint Salvy Anne-Francois de Bourdoncle director | AGrant or award Stock Options (Right to Buy)derivative | +3,432 | $0.00 | $0 | 37,766 | 19 d ago |
| Sep 21, 2026 | Stefano Buono Chief Executive Officer | AGrant or award Stock Options (Right to Buy)derivative | +4,291 | $0.00 | $0 | 4,291 | 19 d ago |
| Sep 21, 2026 | Andrea Ruben Osvaldo Levi director | AGrant or award Class B Sharesderivativeindirect: By DAL 1802 Educazione Cultura Salute | +110,561 | $0.00 | $0 | 110,561 | 19 d ago |
| Sep 21, 2026 | Elisabeth Rizzotti Deputy Ch Ex Off & Ch Oper Off | AGrant or award Stock Options (Right to Buy)derivative | +3,759 | $0.00 | $0 | 3,759 | 19 d ago |
| Sep 21, 2026 | Stefano Buono Chief Executive Officer | AGrant or award Stock Options (Right to Buy)derivative | +9,814 | $0.00 | $0 | 9,814 | 19 d ago |
| Sep 21, 2026 | Elisabeth Rizzotti Deputy Ch Ex Off & Ch Oper Off | AGrant or award Stock Options (Right to Buy)derivative | +7,416 | $0.00 | $0 | 7,416 | 19 d ago |
| Sep 21, 2026 | Stefano Buono Chief Executive Officer | AGrant or award Class B Sharesderivative | +11,960 | $0.00 | $0 | 11,960 | 19 d ago |
| Sep 21, 2026 | Elisabeth Rizzotti Deputy Ch Ex Off & Ch Oper Off | AGrant or award Stock Options (Right to Buy)derivative | +12,418 | $0.00 | $0 | 12,418 | 19 d ago |
| Sep 21, 2026 | Stefano Buono Chief Executive Officer | AGrant or award Class B Sharesderivativeindirect: By Elysia Capital I SCSp | +1,921,029 | $0.00 | $0 | 1,921,029 | 19 d ago |
| Sep 21, 2026 | Elisabeth Rizzotti Deputy Ch Ex Off & Ch Oper Off | AGrant or award Class B Sharesderivative | +32,447 | $0.00 | $0 | 32,447 | 19 d ago |
Insiders
Everyone who has filed a Form 4 here.
- Stefano BuonoChief Executive Officer
- d'Ovidio Manfredi Lefebvredirector
- Andrea Ruben Osvaldo Levidirector
- Raffaele Petronedirector
- Elisabeth RizzottiDeputy Ch Ex Off & Ch Oper Off
- Jon StranskeGroup Chief Financial Officer
- de Saint Salvy Anne-Francois de Bourdoncledirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.